# Audit Report — Phase 79: Autonomous Adaptive Experimentation & Scientific Hypothesis Validation
## Pre-Implementation Capability Gap Audit & Subsystem Assessment

**Date**: 2026-10-25  
**Auditor**: Antigravity Assistant (Google DeepMind)  
**Target Repository**: `JARVIS OS`  
**Focus**: Autonomous Adaptive Experimentation, Information Value (Information Gain), Bayesian Belief Updating, and Evidence-Based Stopping Criteria  

---

### Executive Summary

A comprehensive code inspection of JARVIS OS was conducted across Phases 65 through 78 to determine whether an adaptive experimentation and scientific hypothesis validation capability already exists.

**Finding**: While JARVIS OS possesses:
- A/B benchmark execution in isolated sandboxes (`backend/agents/architectural_optimization/experiment_sandbox.py` in Phase 74),
- Prediction drift detection and error calibration (`backend/agents/predictive_calibration/` in Phase 76),
- Evidence verification and claims governance (`backend/agents/evidence_governance/` in Phase 77), and
- Causal graph construction and pairwise discriminating checks (`backend/agents/causal_diagnosis/experiments.py` in Phase 78),

**JARVIS completely lacks an autonomous adaptive experimentation and scientific hypothesis validation capability**.
Existing implementations do not calculate expected information gain, do not evaluate candidate experiments against cost/risk trade-offs, do not update posterior belief distributions across competing hypotheses, and do not possess evidence-grounded stopping criteria.

---

### 1. Existing Capabilities & Source Files

| Subsystem | Source Path | Existing Experimentation / Hypothesis Capabilities |
|---|---|---|
| **Phase 71 Production Operations** | `backend/agents/production_operations/diagnosis.py` | Single-hypothesis string matching with hardcoded confidence numbers. No experiment planning. |
| **Phase 74 Architectural Optimization** | `backend/agents/architectural_optimization/experiment_sandbox.py` | `ExperimentSandbox`: Runs code mutations in disposable git worktrees and measures before/after benchmark metrics. It is an execution harness, not an information-theoretic selector. |
| **Phase 75 Portfolio Orchestration** | `backend/agents/portfolio_orchestration/scheduler.py` | Capacity allocation across engineering roadmaps. Does not evaluate scientific experiments. |
| **Phase 76 Predictive Calibration** | `backend/agents/predictive_calibration/calibrator.py` | Computes error variance and Platt/isotonic calibrations. Does not update hypothesis spaces. |
| **Phase 77 Evidence Governance** | `backend/agents/evidence_governance/verifier.py` | Deterministic claim-to-evidence checker. Does not generate or select experiments. |
| **Phase 78 Causal Diagnosis** | `backend/agents/causal_diagnosis/experiments.py` | `DiagnosticExperimentPlanner`: Allows manual formulation of a pairwise check (`plan_discriminating_experiment`) comparing two hypotheses. Runs a single check without selection ranking, information gain, or belief updates. |

---

### 2. Does Experiment Selection Consider Information Gain or Uncertainty Reduction?

**No**.
In Phase 78 (`experiments.py`), `plan_discriminating_experiment()` requires the human or caller to provide a specific `inspection_check` for a designated pair `hyp_a` and `hyp_b`. The subsystem:
- Does not maintain a candidate pool of experiments.
- Does not compute Shannon entropy $H(H) = -\sum p_i \log_2 p_i$.
- Does not calculate expected information gain:
  $$\mathbb{E}[\Delta H] = H(H) - \sum_{o \in O} P(o) H(H \mid o)$$
- Cannot quantify how much an experiment reduces uncertainty before execution.

---

### 3. Are Experiments Ranked by Diagnostic Value, Cost, Risk, and Expected Usefulness?

**No**.
Existing tools execute commands directly without cost-utility analysis. There is:
- No cost modeling (execution latency, CPU overhead, network calls).
- No risk modeling (side effects, read-only vs mutating, reversibility).
- No utility optimization function balancing diagnostic power against execution expense.

---

### 4. Do Outcomes Update Competing Hypotheses Consistently?

**No**.
Phase 78's `evaluate_experiment_outcome()` simply checks string substrings to set `status = SUCCESS`, `FAILED`, or `INCONCLUSIVE` on the single tested hypothesis. It:
- Does not maintain a prior probability distribution $P(H_i)$.
- Does not apply Bayesian belief updating:
  $$P(H_i \mid o) = \frac{P(o \mid H_i) P(H_i)}{\sum_j P(o \mid H_j) P(H_j)}$$
- Does not adjust the confidence of untargeted or alternative hypotheses when an experiment provides evidence for or against a shared upstream factor.

---

### 5. Do Stopping Criteria Exist and Are They Evidence-Based?

**No**.
No subsystem in JARVIS OS implements adaptive stopping criteria. Systems either execute a single step and terminate, or run through an entire list of steps until completion or error.
There are no criteria to evaluate:
- Whether posterior certainty exceeds a required threshold ($\max_i P(H_i) \ge \tau_{\text{confirm}}$).
- Whether remaining entropy is negligible ($H(H) \le \epsilon$).
- Whether expected value of further information is less than the cost of obtaining it ($\text{EVOI} < \text{Cost}$).
- When an investigation should be halted because no safe distinguishing experiment exists.

---

### 6. Existing Capabilities to Reuse

Phase 79 must strictly reuse existing foundations without duplicating them:
1. **Phase 78 Causal Diagnosis** (`backend/agents/causal_diagnosis/`):
   - `CausalHypothesis`, `CausalNode`, `CausalEdge`.
   - `DiagnosticExperiment`, `ExperimentScope`, `ExperimentOutcome`.
2. **Phase 77 Evidence Governance** (`backend/agents/evidence_governance/`):
   - Provenance validation, SHA-256 artifact hashing, and freshness tracking.
3. **Phase 76 Predictive Calibration** (`backend/agents/predictive_calibration/`):
   - Uncertainty intervals and error bounding principles.
4. **Phase 75 Portfolio Orchestration** (`backend/agents/portfolio_orchestration/`):
   - Budget constraints and resource allocation limits.
   - `ClaimManager` for execution leases.
5. **Phase 65 Safe Self-Modification** (`backend/agents/safe_self_modification/`):
   - Transactional safety, authorization token verification, and rollback controls.

---

### 7. Concrete Demonstrable Gap (Reproducible Scenario)

Consider an incident with 3 competing explanations:
- $H_1$: Database deadlock ($P=0.40$)
- $H_2$: Connection pool starvation ($P=0.35$)
- $H_3$: Network switch packet loss ($P=0.25$)

And 3 candidate experiments:
- $E_1$: Read-only metric poll of DB pool (`pool.active == max`). Cost: 5ms, Risk: 0.0. High discrimination between $H_2$ and $\{H_1, H_3\}$.
- $E_2$: Thread dump inspection (`jstack`). Cost: 200ms, Risk: 0.1. Distinguishes $H_1$ from $\{H_2, H_3\}$.
- $E_3$: Active packet capture (`tcpdump`). Cost: 5000ms, Risk: 0.8. Requires Tier 4 authorization.

**Existing Code Failure**:
Phase 78 cannot evaluate which experiment yields the highest information gain per unit of cost/risk. It cannot select $E_1$, update posterior beliefs after observing $E_1$, and determine whether $E_2$ is still needed or whether investigation should stop.

---

### 8. Clear Audit Decision

**DECISION: IMPLEMENT PHASE 79 — AUTONOMOUS ADAPTIVE EXPERIMENTATION & SCIENTIFIC HYPOTHESIS VALIDATION**.

The audit demonstrates a clear, verified capability gap. Implementing Phase 79 establishes a principled, information-theoretic scientific investigation engine in `backend/agents/adaptive_experimentation/` (mirrored 1:1 to `agents/adaptive_experimentation/`), reusing Phase 78 hypothesis models, Phase 77 evidence governance, and Phase 65 authorization controls.
